-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- Calidi Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $8K, a 100% increase year-over-year.
- Calidi Biotherapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $20K, a 5.26% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $16K, a 45.5% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)